Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Veltuzumab and Milatuzumab in Relapsed/Refractory B-cell NHL
NCT00989586Phase 2Completed
- Start
- Sep 2009
- Primary completion
- Apr 2015
- Modality
- IgG Antibodies
- Countries
- 1
01
Overview
Phase 2, open-label trial of veltuzumab and milatuzumab in B-cell non-Hodgkin lymphoma. Started Sep 2009; status: completed.
02
Drugs
veltuzumabmilatuzumab
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT00989586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00989586.